(C) PLOS One [1]. This unaltered content originally appeared in journals.plosone.org.
Licensed under Creative Commons Attribution (CC BY) license.
url:https://journals.plos.org/plosone/s/licenses-and-copyright

------------



Thrombospondin-1 expression and modulation of Wnt and hippo signaling pathways during the early phase of Trypanosoma cruzi infection of heart endothelial cells

['Ashutosh Arun', 'Department Of Microbiology', 'Immunology', 'Physiology', 'Meharry Medical College', 'Nashville', 'Tennessee', 'United States Of America', 'Kayla J. Rayford', 'Ayorinde Cooley']

Date: 2022-01 

Abstract The protozoan parasite, Trypanosoma cruzi, causes severe morbidity and mortality in afflicted individuals. Approximately 30% of T. cruzi infected individuals present with cardiac pathology. The invasive forms of the parasite are carried in the vascular system to infect other cells of the body. During transportation, the molecular mechanisms by which the parasite signals and interact with host endothelial cells (EC) especially heart endothelium is currently unknown. The parasite increases host thrombospondin-1 (TSP1) expression and activates the Wnt/β-catenin and hippo signaling pathways during the early phase of infection. The links between TSP1 and activation of the signaling pathways and their impact on parasite infectivity during the early phase of infection remain unknown. To elucidate the significance of TSP1 function in YAP/β-catenin colocalization and how they impact parasite infectivity during the early phase of infection, we challenged mouse heart endothelial cells (MHEC) from wild type (WT) and TSP1 knockout mice with T. cruzi and evaluated Wnt signaling, YAP/β-catenin crosstalk, and how they affect parasite infection. We found that in the absence of TSP1, the parasite induced the expression of Wnt-5a to a maximum at 2 h (1.73±0.13), P< 0.001 and enhanced the level of phosphorylated glycogen synthase kinase 3β at the same time point (2.99±0.24), P<0.001. In WT MHEC, the levels of Wnt-5a were toned down and the level of p-GSK-3β was lowest at 2 h (0.47±0.06), P< 0.01 compared to uninfected control. This was accompanied by a continuous significant increase in the nuclear colocalization of β-catenin/YAP in TSP1 KO MHEC with a maximum Pearson correlation coefficient of (0.67±0.02), P< 0.05 at 6 h. In WT MHEC, the nuclear colocalization of β-catenin/YAP remained steady and showed a reduction at 6 h (0.29±0.007), P< 0.05. These results indicate that TSP1 plays an important role in regulating β-catenin/YAP colocalization during the early phase of T. cruzi infection. Importantly, dysregulation of this crosstalk by pre-incubation of WT MHEC with a β-catenin inhibitor, endo-IWR 1, dramatically reduced the level of infection of WT MHEC. Parasite infectivity of inhibitor treated WT MHEC was similar to the level of infection of TSP1 KO MHEC. These results indicate that the β-catenin pathway induced by the parasite and regulated by TSP1 during the early phase of T. cruzi infection is an important potential therapeutic target, which can be explored for the prophylactic prevention of T. cruzi infection.

Author summary Trypanosoma cruzi, the causative agent of Chagas disease, is now considered a global health threat in all industrialized regions of the world. About 30% of infected individuals will develop cardiac pathology. The molecular mechanisms by which the parasite signals and infect host cells to cause pathology remain to be elucidated. We showed that host thrombospondin-1 (TSP1) is essential for T. cruzi infection since cells deficient in TSP1 are poorly infected by the parasite. In this study, we challenged mouse heart endothelial cells from wild type and TSP1 KO mice and evaluated the importance of TSP1 in Wnt/β-catenin signaling, β-catenin/YAP colocalization and how it can be exploited to regulate parasite infectivity. The parasite activated Wnt/β-catenin signaling pathway and nuclear β-catenin/YAP colocalization. In TSP1 KO MHEC (absence of TSP1), the parasite induced a continuous increase in nuclear translocation and colocalization of β-catenin/YAP. These results suggest that during the early phase of T. cruzi infection, TSP1 regulates β-catenin/YAP interaction. Inhibition of the Wnt/β-catenin pathway in WT MHEC led to a significant reduction of parasite infectivity. The level of parasite infection of the pretreated WT cells was as low as that of TSP1 KO MHEC. Our studies show that the β-catenin pathway is an important therapeutic target for T. cruzi infection.

Citation: Arun A, Rayford KJ, Cooley A, Rana T, Rachakonda G, Villalta F, et al. (2022) Thrombospondin-1 expression and modulation of Wnt and hippo signaling pathways during the early phase of Trypanosoma cruzi infection of heart endothelial cells. PLoS Negl Trop Dis 16(1): e0010074. https://doi.org/10.1371/journal.pntd.0010074 Editor: Jair Lage Siqueira-Neto, University of California San Diego, UNITED STATES Received: December 12, 2020; Accepted: December 8, 2021; Published: January 5, 2022 Copyright: © 2022 Arun et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Data Availability: All relevant data are within the manuscript. Funding: This work was supported by NIH grants 1SC1AI27352 (PNN), 2T32AI007281-31 (AC), 2T32HL007737-26 (AC), 5R25GM05994 (KJR), F31AI167579 (KJR), U54MD007586 (FV) P30EY016665 (NS), P30CA014520 (NS), and R01EY026078 (NS). The NS lab is also supported by an unrestricted award from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences, Retina Research Foundation (https://www.med.wisc.edu/). NS is a recipient of a RPB Stein Innovation Award (https://www.rpbusa.org/). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. Competing interests: The authors have declared that no competing interests exist.

Introduction Trypanosoma cruzi, the causative agent of Chagas heart disease is an obligate intracellular parasite that can infect all nucleated cells of the body. The disease, which was originally endemic in Mexico and other Latin American countries, is now present in all economically advanced countries of the world including the United States in particular due to modern globalization making it a new global health threat [1–5]. The disease originally transmitted through the kissing bug vector, Triatoma infestans, has now been shown to be transmitted by several other modes including the use of contaminated blood/blood products, needles, use of contaminated organs during organ transplant and transmission through the oral route during consumption of contaminated foods or drinks [6]. Vertical transmission from mother-to-child has now become a new research and public health policy challenge especially as there is a substantial population of T. cruzi-infected women of childbearing age and congenitally infected infants among the Latin American migrants [7,8]. In addition to vertical transmission, autochthonous vector transmissions have been reported in the emerging infection regions of the world including the United States [9,10]. During the process of cellular infection, invasive T. cruzi trypomastigotes infect host cells and transform to replicative amastigotes within the infected cells. The amastigotes multiply and transform to invasive trypomastigotes, which are released to infect other cells. Some of the released trypomastigotes infect neighboring cells while others are transported in blood through the host’s vascular system to infect cells in distant parts of the body. During parasite transportation in the blood, invasive trypomastigotes interact with and potentially infect endothelial cells lining the internal surface of the vascular wall through which blood is transported. Endothelial cells lining the inner surface of the vascular system are surrounded by the extracellular matrix proteins, which interact with matricellular proteins. Matricellular proteins are extracellular matrix (ECM) proteins that interact with cells and other ECM components to regulate cellular behavior and ECM organization but are not part of the structural elements of the ECM [11–14]. One of the matricellular proteins, thrombospondin-1 (TSP1) is a complex homotrimeric secreted glycoprotein belonging to the group A subfamily of five TSP family members [15]. TSP1 interacts with several extracellular molecules including, matrix regulating enzymes, glycosaminoglycans, growth factors and diverse cellular receptors among others, thereby having an important role in tissue and cellular homeostasis [13,16–19]. TSP1 has been reported to be very essential in cardiovascular health since it plays important roles in the function of vascular cells including vascular smooth muscle cells, inflammatory cells, fibroblasts and endothelial cells [20] which is of interest in this manuscript. We showed that TSP1 plays a very important role in the process of host cell infection by T. cruzi. The parasite induces the expression of TSP1 in host cells, including primary human coronary artery smooth muscle cells, to facilitate cellular infection [21]. However, the changes in cellular homeostasis caused by the parasite induced increase in TSP1 expression remains unknown. Furthermore, we showed that the expressed host TSP1 interacts with T. cruzi calreticulin (TcCRT) on the surface of the parasite to facilitate cellular infection, which was inhibited in the presence of TcCRT monovalent Fab antibody and in the absence of TSP1 [22]. We also showed that higher levels of host TSP1 induced by the parasite dysregulated the levels of phosphorylated proteins and cellular signaling in the challenged cells [23]. We showed that overexpression of TSP1 increased T. cruzi cellular infection while RNAi knockdown or absence of TSP1 led to a significant decrease in cellular infection [21,22]. The Wnt signal transduction cascade plays important roles in cardiac pathophysiology and its dysregulation can lead to cardiac dysfunction, such as cardiac hypertrophy, fibrosis, arrhythmias, and infarction [24–26]. In the classical canonical Wnt signaling pathway, when a Wnt ligand is absent, the Wnt-off state, a destruction protein complex is formed. The complex is composed of a scaffolding protein axin, adenomatous polyposis coli (APC) tumor suppressor protein, glycogen synthase kinase 3β (GSK3β), and casein kinase 1 (CK1). The GSK3β component of the complex phosphorylates β-catenin at amino acid residues Ser33, Ser37 and Thr41 at the amino-terminal end of β-catenin, while the CK1 component phosphorylates β-catenin at the amino acid residues Ser45 [27,28]. This phosphorylation pattern on β-catenin signals the ubiquitination and subsequent proteasomal degradation of the post-translationally modified β-catenin. Consequently, β-catenin does not translocate to the nucleus and the repressor complex composed of T-cell specific factor (TCF)/lymphoid enhancer-binding factor (LEF) and transducing-like enhancer protein (TLE)/Groucho bind to specific regions of cellular DNA to block the transcription of Wnt responsive genes [29–31]. When a Wnt ligand is present, the Wnt-on state, it binds to one of several Frizzled (Fz) receptors and the low-density lipoprotein (LDL) receptor–related protein (LRP)5/6 coreceptors to activate the canonical Wnt signaling pathway. The cytoplasmic tail of LRP is phosphorylated by GSK3β and CK1 and becomes activated [32,33]. The activated transmembrane co-receptors (Fz and LRP) recruit the cytoplasmic protein dishevelled (Dvl) to the cell membrane, thus, sequestering the rate-limiting components axin and GSK3β from forming the destruction complex [34]. The hypo-phosphorylated/stabilized form of cytosolic β-catenin accumulates and is translocated to the nucleus to displace the inhibitor Groucho, interact with the TCF/LEF family of transcription factors and activate transcription of Wnt responsive genes [27,30,31,35]. The Hippo signaling pathway, which was originally identified in Drosophila melanogaster has now been extensively reported in mammalian cells. This pathway plays an important evolutionarily role in the regulation of organ size, cell proliferation, and apoptosis [36,37]. In mammals, when the canonical Hippo signaling cascade is turned on, serine residues (S127 and 381) in the Hippo effector Yes-associated protein (YAP) and serine residues (S89 and 311) in the transcriptional coactivator with PDZ-binding motif (TAZ) are phosphorylated initially by activated LATS1/2—MOB1A/B complex followed by CK1 kinase. The phosphorylation pattern on the YAP/TAZ effector molecules is a signal for interaction with 14-3-3 for cytoplasmic retention or ubiquitination-mediated degradation [38–40]. In contrast, when the pathway is turned off, YAP/TAZ are not phosphorylated. They are translocated into the nucleus where they interact with TEA domain family members/transcription enhancer factor (TEADs/TEF) family of transcriptional co-activators to promote transcription of downstream genes including TSP1, which plays an important role in cell growth and proliferation [38,41]. Recently, multiple layers of complex crosstalk between Wnt signaling and YAP/TAZ activity have been reported in several different contexts, especially in linking fibrosis and cancer research [42]. YAP/TAZ cooperation with β-catenin has been suggested to be essential for the induction of gastrointestinal tumorigenesis [43,44]. Furthermore, transgene YAP overexpression in intestinal epithelial cells increased both β-catenin expression and their downstream transcriptional targets including cyclin D1 [45]. We showed that T. cruzi upregulates the expression of TSP1, which is downstream of hippo signaling during the early phase of infection. However, the crosstalk between Hippo and Wnt signaling pathways and the role that TSP1 plays in that crosstalk during the early phase of T. cruzi infectivity remains unknown. We hypothesize that during the early phase of molecular interaction between T. cruzi and heart endothelial cells, TSP1 plays an important role in the nuclear colocalization/crosstalk between the Hippo effector molecule YAP, and the Wnt effector molecule β-catenin through an unknown mechanism. To delineate the significance of TSP1 expression on YAP and β-catenin nuclear colocalization during the early phase of infection, we challenged MHEC from wild type (WT) and TSP1 knockout (TSP1 KO) mice with T. cruzi. We evaluated the kinetics of Wnt signaling pathway-associated proteins, nuclear translocation of hippo effector molecule YAP, and its nuclear colocalization with β-catenin. Here we show that in the absence of TSP1 (TSP1 KO MHEC) the parasite induces an increase in the levels of β-catenin in the total cell lysate and in the nuclear compartment. This was accompanied by a significant increase in the nuclear translocation of YAP and its colocalization with β-catenin. In contrast, in the presence of TSP1, WT MHEC, we observed a decrease in the levels of nuclear translocated β-catenin and a consequent significant decrease in YAP/β-catenin nuclear colocalization. To further evaluate the significance of these effector molecules in the process of T. cruzi cellular infection, we preincubated WT MHEC with 20 μM endo-IWR 1 inhibitor, which increases axin2 protein expression, stabilizes the destruction complex and promotes β-catenin phosphorylation. The pretreated cells were then challenged with the parasite to evaluate alterations in infectivity. We observed that inhibition of β-catenin pathway with endo-IWR 1 significantly reduced the level of T. cruzi infectivity. The level of T. cruzi infection in the endo-IWR1 inhibitor treated WT MHEC was as low as the level of T. cruzi infectivity of TSP1 KO MHEC. Our data advances the understanding of the molecular interactions occurring between endothelial cells and T. cruzi in the presence and absence of TSP1 during the early phase of T. cruzi infection and pathogenesis. Furthermore, our data also show that inhibition of the β-catenin pathway is a potential prophylactic/therapeutic target for the prevention of T. cruzi infection.

Methods Ethics statement The animal studies were carried out in accordance with the protocol number 150514PN093 approved by the Institutional Animal Care and Use Committee (IACUC) of Meharry Medical College. Generation and culture of Mouse Heart Endothelia Cells (MHEC) MHEC were isolated and maintained as previously described for retinal EC [46]. Briefly, hearts were harvested from 4-week-old WT or TSP1 KO Immorto mice as detailed [46]. Hearts (from 3–4 mice) were pooled together and minced in DMEM in a 60 mm tissue culture dish using sterile razor blades followed by digestion in 5 ml of collagenase type I (1 mg/ml in serum free DMEM, Worthington, Lakewood, NJ) for 30–45 min at 37°C. DMEM containing 10% FBS was added and cells were pelleted. The cellular digests were filtered through a double layer of sterile 40 μm nylon mesh (Sefar America Inc., Fisher Scientific, Hanover Park, IL), and cells pelleted at 400x g for 10 min. Cells were washed twice with DMEM containing 10% FBS, resuspended in 1.5 ml of wash medium, and incubated with sheep anti-rat magnetic beads pre-coated with anti-PECAM-1 as described [46]. After affinity binding, magnetic beads were washed extensively with wash medium and bound cells in endothelial cell growth medium were plated into a single well of a 24 well plate pre-coated with 2 μg/ml of human fibronectin (BD Biosciences, Bedford, MA). Endothelial cells were grown in DMEM containing 10% FBS, 2 mM L-glutamine, 2 mM sodium pyruvate, 20 mM HEPES, 1% non-essential amino acids, 100 μg/ml streptomycin, 100 U/ml penicillin, freshly added heparin at 55 U/ml (Sigma, St. Louis, MO), endothelial growth supplement 100 μg/ml (Sigma, St. Louis, MO), and murine recombinant interferon-γ (R & D, Minneapolis, MN) at 44 units/ml. Cells were maintained at 33°C with 5% CO 2 . The beads either fell off, get digested or diluted out as we expand the initial EC isolation. To confirm that these cells are EC, we examined the expression of two endothelial cell specific markers, PECAM-1 and VE-cadherin, by FACS analysis. Nearly 100% of wild type and TSP1 KO MHEC expressed high levels of these markers on their surface. Early passage cultures of WT and TSP1 KO MHEC were used in our studies. Rat heart myocyte culture Rat heart myoblasts (RHM) were maintained in DMEM containing glutamax (Life Technologies), 10% heat inactivated fetal bovine serum (Life Technologies), 1% Penicillin/Streptomycin (Life Technologies), 1% Non-essential amino acid and multivitamin (Life Technologies). RHM were grown in humidified tissue culture incubator at 37°C and 5% CO 2 . Invasive T. cruzi trypomastigote generation and infection assays Rat heart myoblasts (RHM) used for the generation of invasive T. cruzi trypomastigotes clone MMC 20A (Tulahuen strain) were maintained in DMEM containing glutamax (Life Technologies), 10% heat inactivated fetal bovine serum (Life Technologies), 1% Penicillin/Streptomycin (Life Technologies), 1% Non-essential amino acid and multivitamin (Life Technologies) at 37°C and 5% CO 2 . RHM monolayers (80% confluency) infected with T. cruzi trypomastigotes clone MMC 20A (Tulahuen strain) were fed with fresh complete medium daily. Released pure population of highly invasive T. cruzi trypomastigotes were harvested as previously described [47–49]. The parasites were washed in Hank’s Balanced Salt Solution (HBSS) and resuspended in MHEC growth medium without supplement at a concentration of 1x107 parasites/ml for use in our experiments. Transgenic T. cruzi trypomastigotes clone MMC 20A (Tulahuen strain) overexpressing green fluorescent protein (GFP–T. cruzi) were similarly generated [22,50]. For infection assays, MHEC monolayers (approximately 85% confluency) were starved in medium without supplements followed by addition of invasive T. cruzi trypomastigotes at a ratio of 10 parasites per cell. Cells challenged with the parasites were incubated for different time points 1, 2, 3 and 6 hours, respectively. At the end of each time point, parasites were washed with 1x DPBS (without calcium/magnesium) and the cells were either stored at -80°C or processed immediately for western blot analysis. The biological replicates of each time point were prepared in independent T75 flasks for use in the western blotting experiments or independent sets of 6 well culture plates containing coverslip coated with 1% gelatin for use in confocal immunofluorescence microscopy assays. Mock-infected (medium only) MHEC were used as control for each time point. For fluorescence microscopy, infection assays were similarly performed on 6 well plastic culture plates. NucBlue Live ReadyProbes Reagent (Thermofisher Cat #R37605) was added to the cells as a nuclear stain, 2 drops/mL of media, for 20 minutes and washed, essentially as described by manufacturer. Cells were also incubated with CellMask Orange Actin Tracking Stain (Thermofisher Cat #A57247) at 1:1000 dilution for 40 minutes to stain actin and washed essentially as described by the manufacturer. The stained cells were visualized using the Keyence All-in-One Fluorescence Microscope BZ-X710 and analyzed with BZ-X Analyzer software. Immunoblotting assays MHEC (WT or TSP1 KO) monolayers were challenged with T. cruzi trypomastigotes at the different time points (1, 2, 3 and 6 hours) and the parasites were washed off with DPBS (without calcium or magnesium). Control and parasite challenged cell monolayers were lysed in RIPA buffer (Life Technologies) containing protease inhibitor cocktail set III at 1:100 (Calbiochem, Gibbstown, NJ, USA), phosphatase inhibitor cocktails 2 and 3 at 1:100 each (Sigma Aldrich, St. Louis, MO, USA). Whole cell lysates (20 μg/well) were separated by SDS-PAGE using 4–15% gradient polyacrylamide gels and transferred onto nitrocellulose membranes (Life Technologies). The membranes were incubated in Intercept TBS Blocking Buffer (LI-COR Biosciences, Lincoln, Nebraska, USA) followed by incubation with appropriate primary antibody diluted at 1:1000 at 4°C overnight on a shaker; mouse anti-Wnt-5a monoclonal antibody (Santa Cruz Biotechnology, Dallas, Texas, USA; cat no. sc-365370), mouse anti-GAPDH monoclonal antibody (Santa Cruz Biotechnology, cat no sc-47724), rabbit anti-β-Catenin antibody (Cell Signaling Technology, Danvers, Massachusetts, USA; Cat no. 8480), rabbit anti-phospho-GSK-3β (Ser9) antibody (Cell Signaling Technology, Danvers, Massachusetts, USA; Cat no. 5558), rabbit anti-GSK-3β antibody (Cell Signaling Technology, Danvers, Massachusetts, USA; Cat no. 12456). The blots were washed and incubated with the corresponding IRDye secondary antibody (LI-COR 800CW or 680RD anti-mouse/ anti-rabbit) in blocking buffer containing 0.01% Tween 20 for 1 hour at room temperature. The blots were washed and scanned using the infrared fluorescence detection Odyssey Imaging System (LI-COR Biosciences) to visualize the bound antibody. Housekeeping GAPDH signal was used for normalization of loading differences. Total GSK-3β signal was used for normalization of the level of phospho-GSK-3β (Ser9). For evaluation of the levels of YAP and β-catenin in the nuclear compartment by immunoblotting, parasite challenged and time matched control MHEC cells were washed in cold PBS and resuspended in hypotonic buffer (20 M Tris-HCl, pH 7.4, 25 mM HEPES, 10 mM NaCl, 3 mM MgCl 2 ) containing protease inhibitor cocktail set III and phosphatase inhibitor cocktails 2 and 3 at 1:100 each followed by addition of 10% NP-40. The cells were vortexed centrifuged for 10 minutes at 3000 rpm at 4°C. Cytoplasmic extraction was done twice and the nuclear pellet was resuspended in the cell extraction buffer (20 M Tris-HCl, pH 7.4, 25 mM HEPES, 10 mM NaCl, 3 mM MgCl 2 ) containing protease inhibitor cocktail set III and phosphatase inhibitor cocktails 2 and 3 at 1:100 each. The lysed nuclear fraction was centrifuged for 30 minutes at 14,000g at 4°C. The supernatant nuclear fraction was used in our assays. Nuclear lysates (20 μg/well) were separated by SDS-PAGE using 12% polyacrylamide gels and transferred onto nitrocellulose membranes. The membranes were blocked with Intercept TBS Blocking Buffer (LI-COR Biosciences) followed by incubation with the appropriate primary antibody (1:1000) at 4°C overnight on a shaker; rabbit anti-β-Catenin antibody (CST; Cat no. 8480), rabbit anti-GSK-3β antibody (CST; Cat no. 12456), mouse anti-HDAC (CST; Cat no. 5356) and mouse anti-GAPDH monoclonal antibody (SCBT; Cat no sc-47724). The blots were washed and incubated with the corresponding IRDye secondary antibody (LI-COR 800CW or 680RD anti-mouse/ anti-rabbit) in blocking buffer containing 0.01% Tween 20 for 1 hour at room temperature and scanned using the Odyssey Imaging System (LI-COR Biosciences) to visualize the bound antibody. The HDAC signal was used for normalization of loading differences and GAPDH signal was used to check for cytoplasmic contamination of the nuclear extract. Each experiment was done in biological triplicates and quantitation of band intensity was performed by densitometry using Image J. Statistical analysis of each parameter for the T. cruzi treated groups compared with non-treated control groups (mock infected groups, 0 h) using student’s t-test or one-way ANOVA (non-parametric) with Newman-Keuls post-hoc test. The difference was considered statistically significant if *P< 0.05, **P< 0.01 and ***P< 0.001 vs control. Immunofluorescence assays MHEC were seeded on glass coverslip coated with 1% gelatin in 6-well culture plate. T. cruzi trypomastigotes Tulahuen strain clone MMC 20A (10 parasites per cell) were incubated with the MHEC for different times 1, 2, 3 and 6 h. The parasites were washed off with DPBS. The cells were fixed with 4% paraformaldehyde for 5 min at room temperature and washed with 1x DPBS. Fixed cells were perforated with 0.1% Triton-X100 in TBS for 5 min and blocked with 3% BSA-PBS for 30 min at room temperature. For evaluation of nuclear translocation, slides were incubated with rabbit anti-β-Catenin monoclonal antibody diluted 1:100 (Cell Signaling Technology, Danvers, Massachusetts, USA; Cat no. 8480) and phalloidin (1:2,000) in 1% BSA-PBS at 4°C overnight. The cells were washed with 1% BSA-PBS and re-probed with goat anti rabbit IgG secondary antibody conjugated with Alexa flour 647 (1:1,000) in wash buffer for 1 h. They were further washed and mounted with mounting medium containing DAPI (Life Technologies) to stain the nuclei. For colocalization assays, the fixed, perforated and blocked cells on the slides were incubated with a mixture of antibodies containing mouse anti-YAP monoclonal antibody diluted 1:100 (Santa Cruz Biotechnology cat no. sc-271134), rabbit anti-β-Catenin (D10A8) monoclonal antibody (Cell signaling Technology, cat no. 8480) diluted1:100, and phalloidin (1:2,000) at 4°C overnight. The cells were washed and the bound primary antibodies were detected using the corresponding secondary antibodies cocktail; goat anti-mouse Alexa fluor 488 and goat anti-rabbit Alexa fluor 647 antibodies diluted 1:1,000 in 1% BSA-PBS for 1 h at room temperature, washed and mounted with mounting media containing DAPI to stain the nuclei. The coverslips with treated cells were transferred on to glass slides and sealed. Stained slides were analyzed using the Nikon A1R confocal microscope located at the Centralized Core Facility at Meharry Medical College. Cellular and nuclear intensities including Pearson’s correlation coefficient for colocalization of signals were determined by imaging software NIS Elements AR Analysis version 5.20.02 64-bit. Wnt/β-catenin pathway inhibition and infection assays To evaluate the importance of Wnt signaling pathway in the process of T. cruzi infection, we preincubated MHEC in the presence or absence of 20 μM endo-IWR1 inhibitor, challenged them with GFP–T. cruzi and evaluated the level of cellular infection by reading the fluorescence intensity of GFP parasites in the cells with a fluorimeter and confocal microscopy assays. For the fluorometric assays, WT MHEC monolayers growing on 1% gelatin precoated 48-well plates were pretreated with or without 20 μM of endo-IWR1 inhibitor for 72 hours. The preincubated WT MHEC were challenged with GFP- T. cruzi parasites at a ratio of 10 parasites per cell. The challenged cells received fresh complete medium daily for 72 h. At the end of 72 h, the cells were washed with 1x DPBS (without calcium/magnesium) and the GFP intensity was read. Fluorescence intensities were recorded at an emission of 485/20 and excitation of 528/20 using a microplate reader (BioTek SYNERGY, SOTWARE Gen5 version 2.05) and compared to similarly treated control cells not challenged with the transgenic parasites. Each biological replicate was prepared in triplicates. TSP1 KO MHEC challenged with GFP–T. cruzi in the absence of the inhibitor were treated similarly. The average mean fluorescence intensity of infected MHEC replicates with or without inhibitor treatment compared to their respective uninfected controls were calculated and plotted using the graphpad prism software package. For the fluorescence microscopy assays, WT MHEC seeded on 6 well plastic culture plates coated with 1% gelatin were pretreated with or without 20 μM endo-IWR1 for 72 h. The cells were then challenged with GFP–T. cruzi at a ratio of 10 parasites per cells and fed with fresh complete medium daily for 72 h. The cells were washed with 1x DPBS (without calcium/magnesium). Live cells were stained with NucBlue Live ReadyProbes Reagent CellMask, Orange Actin Tracking Stain as described by the manufacturer (Thermofisher) and visualized using the Keyence All-in-One Fluorescence Microscope BZ-X710 and analyzed with BZ-X Analyzer software located at the Centralized Core Facility at Meharry Medical College. Statistical analysis Data from at least three biological independent experiments are expressed as mean ± SEM. Statistical comparisons were made between controls and T. cruzi treated groups. Statistical analysis was done using Student’s t-test or one-way analysis of variance (ANOVA) for multiple groups of data followed by a Newman-Keuls test. P-value strength increases with number of asterisks P<0.05 (*), P<0.01 (**), and P<0.001 (***). Statistical analyses were performed using GraphPad Prism (GraphPad Software, San Diego, CA, USA).

Discussion Chagas disease caused by the parasite T. cruzi is a major cause of cardiac pathology in approximately 30% of infected individuals. The parasite infects all nucleated cells of the body including endothelial cells [2]. Invasive trypomastigotes released from infected cells are carried in the blood to infect cells and organs that are nearby or distant from site of parasite release. During the process of transportation, the parasites can signal, interact and infect heart endothelial cells causing disease. Endothelial cells are very important in the process of T. cruzi infection and pathogenesis because parasites are evident in these cells before parasitemia can be detected implying that coronary endothelial cells constitute the primary or initial target of T. cruzi infection [51]. Despite the significance of endothelial cells in the pathogenesis of T. cruzi infection, the molecular mechanisms by which the parasite signal and infect heart endothelial cells remain to be completely characterized despite ongoing research. Elucidation of the molecular interaction between T. cruzi and heart endothelial cells can be exploited for the development of novel molecular intervention strategies. We showed that during the early phase of infection, T. cruzi induces host cells to upregulate TSP1 expression both at the transcript and protein levels. Increased expression of host TSP1 is essential for infection since downregulation of TSP1 expression by RNAi or use of inhibitors that reduce TSP1 expression significantly abrogates the host cell infection with the parasite [21]. Additionally, in an ex vivo model using mouse embryo fibroblasts (MEF), we showed that MEF generated from TSP1 KO mice were significantly less infected compared to MEF from WT mice supporting the importance of TSP1 in the process of cellular infection [22]. The upregulation of TSP1 by the parasite during cellular infection activates transforming growth factor beta (TGFβ), which has been suggested to play important roles in T. cruzi infection and cardiovascular health including the functioning of vascular cells like endothelial cells [52,53]. Furthermore, we recently showed that the parasite regulates expression of PIWI-interacting RNA (piRNA) that can target TGFβ [54]. Elucidation of the host cells signaling mechanisms dysregulated by increased TSP1 expression to enhance cellular infection and pathogenesis remains an important aspect of T. cruzi research. We recently showed that TSP1 plays an important role in the dysregulation of the hippo signaling pathway during the early phase of T. cruzi infection [55]. In addition, it was suggested that the Wnt/β-catenin pathway is activated early after T. cruzi infection of bone marrow derived macrophages [56]. However, the significance of TSP1 expression in activation of the Wnt/β-catenin pathway, including the possibility of molecular interaction between YAP and β-catenin, during the early phase of infection remains unknown. Thus, we hypothesize that during the early phase of molecular interaction between T. cruzi and heart endothelial cells, TSP1 plays an important role in the nuclear crosstalk between the Hippo effector molecule, YAP and the Wnt effector molecule, β-catenin, and that disruption of this suggested crosstalk will affect parasite cellular infectivity. To investigate the significance of TSP1 expression in the molecular colocalization between YAP and β-catenin during the early phase of cellular infection, and how this colocalization affects parasite infection of heart endothelial cells in vitro, we challenged MHEC from WT and TSP1 KO mice with invasive T. cruzi trypomastigotes Tulahuen strain clone MMC20A for different times. We evaluated the activation of Wnt/β-catenin pathway, the molecular colocalization of Wnt/Hippo signaling pathway effector molecules, and how its disruption could affect the early phase of T. cruzi infection. Our data showed that the parasite turns on the Wnt signaling pathway in MHEC in a TSP1 dependent manner. Specifically, in the absence of TSP1, the levels of the Wnt ligand, Wnt-5a, which activates the Wnt signaling pathway was significantly increased at 1, 2 and 3 h time points while it remained toned down and steady in the presence of TSP1 (Fig 1A and 1B). Thus, TSP1 expression may suppress Wnt signaling and as a result enhance infection. Our observations agree with others who suggested that the parasite can activate Wnt proteins during the early phase of cellular infection [56]. Additionally, we showed that the degree of activation of Wnt-5a is affected by TSP1 expression during the early phase of infection. Furthermore, we showed that the parasite significantly increased the levels of p-GSK-3β and accordingly significantly decreased the level of GSK-3β post challenge in TSP1 KO MHEC compared with an opposite observation in WT MHEC (Fig 2A and 2B). Our observations support the contemporary knowledge which suggests that Wnt ligands bind to Fzd receptors to activate the Wnt signaling pathway by inhibition of GSK-3β activity through its phosphorylation which disrupts the formation of the β-catenin destruction complex [27,29,31]. In agreement with the significant activation of Wnt signaling cascade proteins and the deactivation of the destruction complex (Figs 1 and 2), the level of β-catenin in TSP1 KO MHEC lysate showed a significant increase following parasite challenge (Fig 3B) compared with control. In WT MHEC, the level of β-catenin decreased to a minimum at 2 h followed by a gradual increase (Fig 3A). Our data agrees with others who showed that destabilization of the destruction complex limits β-catenin phosphorylation, ubiquitination and proteasomal degradation with a consequent accumulation of the protein in the cytoplasm [34,57,58]. Furthermore, our data showed that the increase in β-catenin levels in the absence of TSP1 was accompanied by an increase in the nuclear translocation of β-catenin in TSP1 KO MHEC, where we observed a continuous increase in nuclear β-catenin (Fig 5A and 5B). In contrast, in WT MHEC we observed a significant decrease in nuclear translocation of β-catenin (Fig 4A and 4B). This immunofluorescence microscopy observations were supported by immunoblotting assays showing increased levels of β-catenin and YAP in nuclear extracts of parasite challenged TSP1 KO MHEC (Fig 6B). This increase was specifically induced by the parasite challenge since time matched controls showed no significant changes in the levels of β-catenin or YAP in WT or TSP1 KO MHEC, respectively (S1 Fig). Others also reported that when the Wnt signaling pathway is turned on, the downstream effector molecule, β-catenin is translocated into the nucleus [29,59]. Others suggested that fold change rather than absolute β-catenin levels are critical indicating that low levels of nuclear β-catenin translocation would be sufficient for initiation of transcriptional changes [60]. Experimental models showed that overexpression and nuclear accumulation of β-catenin triggered a fibrogenic response, however, β-catenin depletion in the same model did not abrogate a fibrogenic response indicating that the Wnt signaling pathway functions in collaboration with other signaling pathways to induce a fibrogenic response [58,61]. Since we showed that TSP1 dysregulates YAP nuclear translocation during the early phase of infection, we evaluated whether Wnt/β-catenin and YAP molecules colocalize in the nuclear compartment during the early phase of infection especially as TSP1 is important for T. cruzi infection and pathogenesis. Our current studies evaluating the nuclear colocalization of β-catenin and YAP during the early phase of T. cruzi infection, opened up new studies in our laboratory geared towards deciphering the molecular mechanisms operating in the presence and absence of TSP1. Our data revealed, for the first time, in the context of T. cruzi research that in the presence of TSP1 (WT MHEC), the parasite induced nuclear colocalization of β-catenin and YAP (Fig 7A and 7B), while in the absence TSP1 (TSP1 KO MHEC) the level of β-catenin/YAP nuclear colocalization showed a gradual increase from 2 to 6 h (Fig 8A and 8B). Immunoblotting assays using nuclear extracts of parasite challenged MHEC showed the presence of both molecules (Fig 6). Others have suggested the existence of a complex crosstalk between YAP and β-catenin in several systems where YAP regulated β-catenin activity and β-catenin regulated YAP/TAZ activity, and they have been suggested to be involved in the pathogenesis of tissue fibrosis and tumorigenesis [32,33,45,57,58]. Considering our data showing that the Pearson’s correlation coefficient of YAP/β-catenin nuclear colocalization is significantly increased in the absence of TSP1, supported by data showing increasing amounts of both molecules in nuclear extracts (Fig 7B), coupled with our previous report that T. cruzi infection ex vivo and in vitro is significantly reduced in the absence of TSP1, or when TSP1 is knocked down by RNAi, respectively [21,22], we preincubated WT MHEC with endo-IWR 1, an inhibitor of Wnt signaling and evaluated T. cruzi infectivity. Our data showed that inhibition of the Wnt signaling pathway significantly reduced T. cruzi infection of WT MHEC. The level of infection of the WT MHEC pretreated with endo-IWR 1 was reduced to that of T. cruzi infection of TSP1 KO MHEC. A decrease in the level of infection in the inhibitor treated cells also led to a decrease in parasite density in the infected cells (Fig 9A–9D). Others showed that inhibition of the Wnt signaling pathway decreased parasite multiplication [56]. In that study, it was not clear if T. cruzi infectivity was similar in cells pretreated or not with Wnt pathway inhibitors. We and others now show that inhibition of the Wnt/β-catenin signaling pathway significantly decreased parasite infection and multiplication. These results suggest that the Wnt pathway inhibition has a potential preventative therapy for T. cruzi infection. Therefore, this pathway can be exploited for the development of specific molecular intervention strategy for the management of T. cruzi infection.

Acknowledgments We are grateful to the Morphology Core, a part of Centralized Core Facility at Meharry Medical College.

[END]

[1] Url: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0010074

(C) Plos One. "Accelerating the publication of peer-reviewed science."
Licensed under Creative Commons Attribution (CC BY 4.0)
URL: https://creativecommons.org/licenses/by/4.0/


via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/plosone/